TD Asset Management’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-8,800
Closed -$511K 1538
2021
Q2
$511K Buy
+8,800
New +$469K ﹤0.01% 1377

Other funds holding HCAT

TD Asset Management's HCAT Position: Q3 2021 in Review

TD Asset Management sold out of Health Catalyst (HCAT) in Q3 2021, closing a stake of 8,800 shares — an estimated $511K sold.

TD Asset Management first reported a position in HCAT in Q2 2021 and held it in 1 quarter. The position peaked at $511K in Q2 2021. 198 funds tracked by Wall St. Rank hold HCAT as of Q3 2021.

  • TD Asset Management reported no remaining Health Catalyst position as of Q3 2021 after selling out during the quarter.
  • TD Asset Management sold 8,800 Health Catalyst shares in Q3 2021, an estimated $511K.
  • TD Asset Management first reported a position in Health Catalyst in Q2 2021 and held it in 1 quarter.
  • TD Asset Management's Health Catalyst position peaked at $511K in Q2 2021.
  • 198 funds tracked by Wall St. Rank held Health Catalyst as of Q3 2021.

Based on TD Asset Management's 13F filing for Q3 2021, filed 9 Nov 2021.